ArticleScientific reports2026
Morphological characterization, divergence and disease reaction studies for improvement of mid-late and late maturity genotypes of cauliflower under North-Western Himalayas.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although numerous varieties have been recommended across different agro-climatic zones of Himachal Pradesh, however the information on high yielding genotypes with higher quality and disease resistance is lacking in this state. Diseases like black rot and stalk rot are the main obstacle preventing cauliflower production in this area. Therefore, in this investigation, thirty genotypes of cauliflower were evaluated for morphological characters based on DUS, horticultural traits, character associations, genetic divergence and disease reaction studies to identify superior genotypes for commercial cultivation. The experiment was designed in Randomized Complete Block Design (RCBD) with three replications. The genotypes were morphologically classified based on twenty-one DUS characters, further identifying genotypes for inclusion in breeding programmes or direct use as a cultivar. Mean performance of genotypes for various traits disclosed that Pusa Himjyoti recorded the highest marketable curd yield/hectare and genotypes Snowball Super, White Heart, UHF-CAU-1, Early Snowball, UHF-CAU-4, UHF-CAU-8 and KT-18 were determined to be statistically at par with Pusa Himjyoti. All these genotypes have white to snow white curd with self- blanching habit. High heritability along with moderate genetic advance as per cent of mean was observed for net curd weight confirming the occurrence of additive gene action. Correlation coefficient discovered that the number of leaves/plant, plant spread, curd polar diameter, curd equatorial diameter, curd size index, curd solidity, gross plant weight and net curd weight were found to be significantly and positively correlated with marketable curd weight. The maximum positive direct effect on marketable curd weight was contributed by curd equatorial diameter followed by curd polar diameter, net curd weight, curd solidity and number of leaves/plant. Thus, perfection in these traits will lead to higher yield in cauliflower. The D2 analysis grouped the genotypes into three clusters consists maximum genotypes in cluster II. Gross plant weight (32.00%), net curd weight (18.16%), plant height (8.33%) and marketable curd yield (8.21%) were identified as significant traits contributing to divergence. In case of disease reaction studies, no genotype was found resistant to stalk rot while, in black rot, only one genotype White Heart was found resistant whereas Snowball Super and PSBK-1 showed moderately resistant reaction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.